Our results can be used by patients and their healthcare providers, as well as policy-makers to guide decision-making regarding use of the anti-VEGF agents
Anti-VEGF agents are effective for improving vision gain, mean BCVA, and reducing vision loss for patients with wet AMD
Compared to placebo, we did not observe an association between their use and increased adverse events or mortality